一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Journal of Medicinal Chemistry >>article
Journal of Medicinal Chemistry

Journal of Medicinal Chemistry

IF: 6.8
Download PDF

Discovery of Potent Dual PROTAC Degraders Targeting BET-Kinase To Overcome FLT3 Inhibitor Resistance

Published:5 August 2025 DOI: 10.1021/acs.jmedchem.5c00831
Qiuping Xiang*, Yujie Sun, Hui Hua, Mengdie Hu, Xiaomei Li, Manyu Guo, Le Niu, Zhang Zhang, Ting Cai and Dongsheng Zhu*, 

Abstract

FMS-like tyrosine kinase 3 (FLT3) is a validated therapeutic target in acute myeloid leukemia (AML). However, numerous single-agent FLT3 or multitarget inhibitors fail to achieve complete and sustained suppression of FLT3 signaling due to the development of drug resistance. Herein, we report the design, synthesis, and evaluation of a novel series of dual BET-kinase degraders targeting FLT3, JAK2, and BRD4. Optimization led to 13e, which efficiently degraded FLT3, JAK2, and BRD4 in MV4;11 cells with DC50 values of 5.23, 0.678, and 1.17 nM, respectively. Mechanistic studies confirmed cereblon- and proteasome-dependent degradation. 13e significantly inhibited MV4;11 cell proliferation and demonstrated promising antitumor activity in an MV4;11 xenograft model. Additionally, 13e showed enhanced antiproliferative activity against FLT3 mutant-transformed Ba/F3 cells, indicating its potential to overcome resistance. Collectively, 13e represents a highly promising FLT3/JAK2/BRD4 degrader with potent antileukemic activity and the ability to overcome resistance associated with current FLT3 inhibitors.

四会市| 兴文县| 广德县| 凤翔县| 兰溪市| 鸡西市| 奉贤区| 梨树县| 教育| 北票市| 龙岩市| 南安市| 视频| 桑日县| 衡山县| 安陆市| 乌拉特中旗| 石家庄市| 都兰县| 富蕴县| 南雄市| 榆社县| 武隆县| 兰考县| 中超| 湘潭县| 铅山县| 云林县| 广汉市| 景谷| 陇川县| 承德县| 彭泽县| 石棉县| 富蕴县| 敦化市| 株洲县| 庄河市| 金寨县| 永城市| 涞水县|